Tag: data

— Registration-enabling study demonstrated high clinically meaningful objective responses, achieving rapid and durable disease control —

TORONTO, Ontario and HAIFA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce today that its wholly owned U.S. subsidiary, Exo-Top Inc. (“Exo-Top”), has entered into a binding memorandum of understanding (the “MOU”) setting out the principal commercial terms for a proposed definitive distribution agreement (the “Definitive Agreement”) with ExoLyra LLC, which operates as an arm’s length third party (“ExoLyra”).

BROOKFIELD, News, June 24, 2026 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Corporation (the “Corporation”) (TSX, NYSE: BIPC) today announced that all nine nominees proposed for election to the board of directors by holders of class A exchangeable subordinate voting shares (“Exchangeable Shares”) and holders of class B multiple voting shares (“Class B Shares”) were elected at the Corporation’s annual meeting of shareholders held on June 24, 2026 in a virtual meeting format. Detailed results of the vote for the election of directors are set out below.